Neogenomics (NEO) Interest Expenses (2011 - 2026)

Neogenomics (NEO) has 17 years of Interest Expenses data on file, last reported at $29.5 million in Q2 2026.

• Quarterly Interest Expenses fell 1.51% year-over-year to $29.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $29.5 million (down 1.51% YoY) and the FY2025 annual result came in at $123.1 million, up 46.7% from the prior year.
• Interest Expenses steadied at $29.5 million in Q2 2026, from $29.5 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $33.5 million in Q2 2022 to a low of -$1.8 million in Q4 2023.
• A 5-year average of $25.4 million and a median of $32.8 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses plunged 135.4% — and 2024, when it soared 317.17%.
• Tracing NEO's Interest Expenses over 5 years: stood at $5.2 million in 2022, then sank by 135.4% to -$1.8 million in 2023, then soared by 317.17% to $4.0 million in 2024, then slumped by 85.06% to $599000.0 in 2025, then jumped by 4829.88% to $29.5 million in 2026.
• The last three Interest Expenses figures came in at $29.5 million (Q2 2026), $29.5 million (Q1 2026), and $599000.0 (Q4 2025), per Business Quant data.